| NCT Number | NCT07548151 |
| Lead Sponsor | X9, Inc. |
| Conditions | End Stage Renal Failure, Hemodialysis, Cannulation |
| Enrollment | 10 participants |
| Start Date | 2026-04-14 |
| Primary Completion | 2026-04-30 (estimated) |
| Study Completion | 2026-04-30 (estimated) |
| Updated on ClinicalTrials.gov | 2026-05-29 |